The so-called “Inflation Reduction Act” that Democrats just passed is really a climate and healthcare spending bill. One of the most consequential healthcare provisions included in the bill is a limit on out-of-pocket prices Medicare beneficiaries can pay for insulin, capping their copays at $35. Republicans voted against expanding this quasi-price-control beyond Medicare to all private health insurance and opposed the broader measure as well.

Recommended Stories

Congress plots overhaul of over-the-counter drug rules

RFK Jr. cuts red tape on biosimilar drugs to lower prescription costs

Medicare could have saved nearly $1 billion by using generics, study finds